The Manufacturers Life Insurance Company Sells 33,337 Shares of Humana Inc. $HUM

Key Points

• The Manufacturers Life Insurance Company reduced its stake in Humana Inc. by 30.6%, now holding 75,607 shares valued at approximately $20 million.
• Humana reported a quarterly EPS of $6.27, missing analyst estimates by $0.05, while its revenue of $32.39 billion exceeded expectations.
• The company announced a $0.885 quarterly dividend, which translates to an annualized payout of $3.54 and a dividend yield of 1.1%.

The Manufacturers Life Insurance Company lowered its position in Humana Inc. (NYSE:HUM - Free Report) by 30.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 75,607 shares of the insurance provider's stock after selling 33,337 shares during the period. The Manufacturers Life Insurance Company owned 0.06% of Humana worth $20,006,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HUM. Vanguard Group Inc. boosted its holdings in Humana by 8.9% in the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock worth $3,697,222,000 after acquiring an additional 1,143,662 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Humana by 40,881.1% in the first quarter. GAMMA Investing LLC now owns 781,099 shares of the insurance provider's stock valued at $2,066,790,000 after purchasing an additional 779,193 shares in the last quarter. Southpoint Capital Advisors LP bought a new position in shares of Humana in the fourth quarter valued at approximately $190,282,000. Nuveen LLC bought a new position in shares of Humana in the first quarter valued at approximately $171,220,000. Finally, Dodge & Cox lifted its holdings in shares of Humana by 5.5% in the first quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider's stock valued at $2,845,830,000 after purchasing an additional 557,175 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on HUM. Royal Bank Of Canada raised their target price on Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a report on Thursday, August 21st. Piper Sandler dropped their target price on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a report on Thursday, July 31st. Wells Fargo & Company dropped their target price on Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a report on Thursday, August 14th. Wall Street Zen lowered Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Finally, Robert W. Baird decreased their price target on Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Seven investment analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the stock. According to MarketBeat.com, Humana currently has a consensus rating of "Hold" and an average target price of $289.24.

Humana Stock Performance

Shares of HUM traded down $4.07 on Friday, reaching $307.94. 1,504,536 shares of the company's stock traded hands, compared to its average volume of 1,364,503. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a market cap of $37.04 billion, a PE ratio of 23.63, a PEG ratio of 1.83 and a beta of 0.44. The stock's 50 day simple moving average is $261.46 and its two-hundred day simple moving average is $256.47. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $369.17.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. During the same period in the prior year, the business earned $6.96 earnings per share. The business's quarterly revenue was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. On average, analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.1%. Humana's payout ratio is 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.